2 assets in Chordoid Glioma Of The Third Ventricle

Therapeutic assets addressing Chordoid Glioma Of The Third Ventricle, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dabrafenib Chordoid Glioma Of The Third Ventricle	Novartis Pharmaceuticals	P4	BB (65)
Trametinib Chordoid Glioma Of The Third Ventricle	Novartis Pharmaceuticals	P4	BB (65)